王鹏
副教授、硕士生导师
研究方向:肿瘤流行病学、肿瘤诊断、肿瘤免疫学
联系电话:0371-67781453
邮箱:wangpeng@zzu.edu.cn

论文

[1] Sun GY, Chen HL, Xia JF, Ye H, Li TD, Li JX, Zhang XY, Cheng YF, Wang KY, Shi JX, Wang P*. Diagnostic performance of anti-MAGEA family protein autoantibodies in esophageal squamous cell carcinoma. International Immunopharmacology, 2023, 125(Pt A): 111041.

[2] Yang Q, Ye H, Sun GY, Wang KY, Dai LP, Qiu CP, Shi JX, Zhu JC, Wang X, Wang P*. Human Proteome Microarray identifies autoantibodies to tumor-associated antigens as serological biomarkers for the diagnosis of hepatocellular carcinoma. Molecular Oncology, 2023, 17(5): 887-900.

[3] Sun GY, Ye H, Liu HJ, Li TD, Li JX, Zhang XY, Cheng YF, Wang KY, Shi JX, Dai LP, Wang P*. ZPR1 is an immunodiagnostic biomarker and promotes the tumor progression in esophageal squamous cell carcinoma. Cancer Science, 2023, doi: 10.1111/cas.16004.

[4] Sun GY, Ye H, Yang Q, Zhu JC, Qiu CP, Shi JX, Dai LP, Wang KY, Zhang JY, Wang P*. Using proteome microarray and gene expression omnibus database to screen tumour-associated antigens to construct the optimal diagnostic model of oesophageal squamous cell carcinoma. Clinical Oncology, 2023, 35(10): e582-e592.

[5] Xie WH, Sui GY, Xia JX, Chen HL, Wang C, Lin J, Wang P*. Identification of novel tumor associated antigens and evaluation of a panel of autoantibodies in detecting oral cancer. BMC Cancer, 2023, 23(1): 802.

[6] Li JX, Chen HL, Sun GY, Zhang XY, Ye H, Wang P*. Role of miR-21 in the diagnosis of colorectal cancer: meta-analysis and bioinformatics. Pathology Research and Practice, 2023, 248: 154670.

[7] Wang KY, Qiu CP, Xing MT, Li M, Wang BF, Ye H, Shi JX, Dai LP, Wang X, Wang P*. Association of elevated autoantibody to high expression of GNAS in hepatocellular carcinoma. Heliyon, 2023, 9(12): e22627.

[8] Chen HL, Sun GY, Han Z, Wang HM, Li JQ, Ye H, Song CH, Zhang JY, Wang P*. Anti-CXCL8 autoantibodya potential diagnostic biomarker for esophageal squamous cell carcinoma. Medicina-Lithuania, 2022,58(10):1480.

[9] Xie WH, Sun GY, Zhu JC, Wang HM, Han Z, Wang P*. Anti-POSTN and anti-TIMP1 autoantibodies as diagnostic markers in esophageal squamous cell carcinoma. Frontiers in Genetics, 2022, 13: 860611.

[10]Li KM, Han Z, Wu JY, Ye H, Sun GY, Shi JX, Zhang JY, Wang P*. The Relationship between MALAT1 Polymorphism rs3200401 C > T and the Risk of Overall Cancer: A Meta-Analysis. Medicina-Lithuania, 2022,58(2):176.

[11]Yang Q, Qin JJ, Sun GY, Qin CP, Jiang D, Ye H, Wang X, Dai LP, Zhu JC, Wang P*, Jianying Zhang*. Discovery and validation of serum autoantibodies against tumor-associated antigens as biomarkers in gastric adenocarcinoma based on the focused protein arrays. Clinical and Translational Gastroenterology, 2021, 12(1): e00284.

[12]Wang HM, Yang XA, Sun GY, Yang Q, Cui C, Wang X, Ye H, Dai LP, Shi JX, Zhang JY,  Wang P*. Identification and evaluation of autoantibody to a novel tumor-associated antigen GNA11 as a biomarker in esophageal squamous cell carcinoma. Frontiers in Oncology, 2021, 11:661043.

[13]Sun GY, Ye H, Wang, Cheng L, Ren PF, Shi JX, Dai LP, Wang P*, Jianying Zhang*. Identification of novel autoantibodies based on the protein chip encoded by cancer-driving genes in detection of esophageal squamous cell carcinoma. Oncoimmunology, 2020, 9(1): e1814515.

[14]Sun GY, Ye H, Wang X, Li TD, Jiang D, Qiu CP, Dai LP, Shi JX, Wang KJ, Song CH, Wang P*, Jianying Zhang*. Autoantibodies against tumor-associated antigens combined with microRNAs in detecting esophageal squamous cell carcinoma. Cancer Medicine, 2020, 9(3):1173-1182.

[15]Qin JJ, Yang Q, Ye H, Wang KY, Zhang M, Zhu JC, Wang X, Dai LP, Wang P*, Zhang JY*. Using serological proteome analysis to identify and evaluate anti-GRP78 autoantibody as biomarker in the detection of gastric cancer. Journal of Oncology, 2020, 2020: 9430737.

论文

[1] Sun GY, Chen HL, Xia JF, Ye H, Li TD, Li JX, Zhang XY, Cheng YF, Wang KY, Shi JX, Wang P*. Diagnostic performance of anti-MAGEA family protein autoantibodies in esophageal squamous cell carcinoma. International Immunopharmacology, 2023, 125(Pt A): 111041.

著作

[1] 王鹏(编委),罕见病临床与诊断(“十二五”国家科技支撑计划). 清华大学出版社(ISBN: 978-7-302-46614-7),2017.

[2] 王鹏(编委、秘书),临床流行病学(医学高职高专“十二五”规划教材). 郑州大学出版社(ISBN:978-7-5645-1017-6),2012.

发明专利

[1] 王鹏(第一发明人),一种用于食管鳞癌辅助诊断的生物标志物及检测试剂盒;专利号:ZL 2021 1 1294764.2